Approximately 70% of primary 7,12-dimethylbenz(alpha)-anthracene-induced mammary
tumors regressed when (
tumor-bearing) rats were made diabetic
after treatment with
streptozotocin. In the intact animal, cyclic
adenosine 3':5"-monophosphate (cAMP) levels of
tumors that regressed following the induction of diabetes were initially 4-fold lower than in unresponsive
tumors but increased 4-fold during regression. The
insulin-independent
tumors showed no statistically significant changes. cAMP binding in cytosol of regressing
tumors was about 80% above the initial values at 36 hr after
therapy but decreased to about 45% 1 week later. On the contrary, the binding capacity of the nuclei showed a 56% increase at 36 hr and increased gradually to about 3-fold 1 week later. Within 36 hr
after treatment, total
histone kinase activity increased 127% in the cytosol and 153% in the nuclei of regressing
tumors. The increment of
histone kinase activity was almost totally in the cAMP-dependent component of the
enzyme. These changes were not apparent in
insulin-independent
tumors. The results are interpreted to indicate that mammary
tumor regression due to diabetes involves the cAMP system and occurs through a sequence of events similar to those observed during regression induced by either
ovariectomy or dibutyryl cAMP (cyclic
adenosine 3':5'-monophosphate) treatment.